Back to Journals » Diabetes, Metabolic Syndrome and Obesity » Emerging therapeutic targets of diabetic nephropathy
SJR OA
CiteScore
Impact Factor
Diabetes, Metabolic Syndrome and Obesity
ISSN: 1178-7007
- View all (3377)
- Volume 19, 2026 (115)
- Volume 18, 2025 (389)
- Volume 17, 2024 (428)
- Volume 16, 2023 (373)
- Volume 15, 2022 (350)
- Volume 14, 2021 (449)
- Volume 13, 2020 (486)
- Volume 12, 2019 (269)
- Volume 11, 2018 (92)
- Volume 10, 2017 (52)
- Volume 9, 2016 (45)
- Volume 8, 2015 (59)
- Volume 7, 2014 (61)
- Volume 6, 2013 (50)
- Volume 5, 2012 (41)
- Volume 4, 2011 (46)
- Volume 3, 2010 (45)
- Volume 2, 2009 (22)
- Volume 1, 2008 (5)
Journal Articles:
- From Type 1 to Type 2 Diabetes and Obesity: The Impact of Continuous Glucose Monitoring (CGM) and Emerging Diabetes Management Technologies on Metabolic Health (1)
- GLP-1 Agonists: The Game-Changers in Type 2 Diabetes and Obesity Care (4)
- The State of Diabetes, Metabolic Syndrome and Obesity (9)
- Managing obesity with pharmacotherapy (7)
- Understanding the Impact of Gender and Sex on Diabetes Incidence, Complications, and Treatment (1)
- Emerging therapeutic targets of diabetic nephropathy (1)
Review
The Role of PKM2 in Diabetic Microangiopathy
Tu C, Wang L, Wei L
Diabetes, Metabolic Syndrome and Obesity 2022, 15:1405-1412
Published Date: 4 May 2022